Authors


Craig Bryan, PsyD, ABPP

Latest:

Suicide Rates During the Pandemic

“The pandemic has perhaps shown us how important social and environmental factors are as influencing factors for suicide prevention.”


Todd Shryock

Latest:

Your Medicare Patients Are Struggling

About 1 in 6 of Medicare patients report trouble paying Medicare bills and debt.


Caroline Gurvich, BA/BSc, DPsych

Latest:

Are There Sex Differences in Cognition and Does It Matter?

Learn more about key findings on sex differences in cognition, exploring the possible causes and implications for clinical practice.


Russell Lim, MD

Latest:

Next Steps: Solutions and Recommendations For Healing

Climate change is a devastating existential threat that can exaggerate preexisting inequities and health/mental health problems. As mental health professionals committed to understanding deep emotional wounds and addressing complexities of relationships, psychiatrists have the tools to assist in bridging the current gaps.


Lindsey MacGillivray, MD, PhD

Latest:

COVID-19 Brings Anosmia to the Attention of Psychiatrists

Loss of smell can be devastating for patients. How can psychiatrists deal with the associated psychological effects?


Robert M. Kaplan, MBChB, FRANZCP, MA, MPhil

Latest:

Reef Madness: Digging up the Dirt on an Australian Myth

“Hunter’s book is excellently written and highly recommended for readers who want to understand the enormous power of myth in the Australian identity.”


Lucy Lan, MD, MBA

Latest:

Perspectives on Global Women’s Mental Health

This diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.


Artem Trotsyuk, MS

Latest:

Chatbots for Child Mental Health Care: Helpful, but Limited

An estimated 7.7 million children have at least 1 mental health disorder. How can chatbots help?


Michelle F. Sloan, MD

Latest:

Treatment-Resistant OCD: Strategies and Novel Treatment Options

OCD is highly comorbid and warrants consideration in difficult to treat cases. Learn more here.


Alyssa J. Asmar, MA

Latest:

Emotion and Cognitive Control: An Essential Partnership for Adaptive Behavior

Disruptions to cognitive control, as well as to emotional processes, are implicated in a wide range of psychiatric disorders.


Jonathan E. Hickman MSN, RN, PMHNP-BC

Latest:

A Case of Clozapine and Cancer

What does cancer treatment mean for psychiatric treatment with clozapine?


Sandra Bond Chapman, PhD

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Here’s why we should be paying special attention to women's depression treatment.


Caleb Rashidian, DO

Latest:

Bella, Horrida Bella

“In the realm of psychiatry, the therapeutic value of poetry lies in its ability to transcend the limitations of prose, offering a space for the unsayable and the ineffable.”


Michelle Raji, MD

Latest:

The Dangers of Inhalant Use Disorder

Inhalant use disorder is a form of substance use disorder characterized by the intentional inhalation of volatile substances for their psychoactive effects.


Stephen Brannan, MD

Latest:

Promising Publication: The Novel Schizophrenia Treatment Gaining Traction

Data published in The New England Journal of Medicine shows promise for a novel schizophrenia treatment.


Benoit H. Mulsant, MD, MS

Latest:

COVID-19, Cognition, and Dementias: What Role Has the Pandemic Played?

How does COVID-19 contribute to cognitive impairment in older adults and future cases of dementia?


Deborah J. Jones, PhD

Latest:

Issues in Regulating DTx

We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?


Sean Pustilnik, MD

Latest:

Incorporating Well-Being Into Child and Adolescent Psychiatry

A well-being centered approach expands assessment and treatment for the child’s strengths and opportunities for positive experiences with the family.


Natasha L. Poulopoulos, PhD

Latest:

The Noxious Psychological Effects of Anti-LGBTQ+ Legislative Bills Sweeping Across the US

The Florida “Don’t Say Gay” bill will have a devastating effect on LGBTQ+ youth.


Alexander deNesnera, MD, DLFAPA

Latest:

Delays in Psychiatric Care: New Hampshire’s Robust Response

New Hampshire’s mental health system faces ongoing challenges with emergency department boarding, legal concerns over due process, and resource shortages, prompting reforms to improve patient care and access.


Wayne Drevets, MD

Latest:

Seltorexant, Major Depressive Disorder, and Insomnia: Thoughts on the New Data

Andrew Krystal, MD, and Wayne Drevets, MD, share their thoughts on the recent seltorexant data presented at the 2024 ASCP Annual Meeting.


Jasna Hocevar-Trnka, MD, MPH

Latest:

RE104: A Novel, Fast-Acting Psychedelic for Postpartum Depression

Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.


Beatrix Taylor, BSc, MSc

Latest:

RE104: A Novel, Fast-Acting Psychedelic for Postpartum Depression

Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.


Gil Angela Dela Cruz, MSc

Latest:

SUDs in Women and the Importance of Tailored Treatment Approaches

What are the most effective approaches to SUD treatment in this unique patient population?


Alex Mendelsohn, PhD

Latest:

Securing the Future of Lithium Research

How can we enhance our lithium research?


Lori Rubenstein

Latest:

Let’s Build Brains Better! Brain Science-Inspired Policies for the Future

In order to face the rapidly changing, increasingly complex, and globally connected world, we need to focus on the importance of early brain and child development.


Barbara Burton, MD

Latest:

Psychopathy: Insights for General Practice

While incarceration is the definitive “treatment” for some, psychopathy exists on a spectrum like any other mental disorder; more recent research suggests the condition is capable of responding to treatment.


Andreas Maercker, MD, PhD

Latest:

Resiliency and Posttraumatic Growth: Cultural Implications for Psychiatrists

Acknowledging a patient's ability to grow and recover may help them feel more understood despite ongoing suffering.


Yaakov S. Green, MD, MBA

Latest:

Adding Insult to Narcissistic Injury: Comorbidity of Narcissistic Personality Disorder and Major Depressive Disorder

Diagnosing this intricate comorbidity demands a nuanced approach. Here's what you need to know.


Lior Hilsenrath, MD

Latest:

Zuranolone for the Treatment of Adults With Major Depressive Disorder

This randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.

© 2025 MJH Life Sciences

All rights reserved.